Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.
JAMA Oncol. 2022 Dec 1;8(12):1809-1815. doi: 10.1001/jamaoncol.2022.5049.
PMID:36264568
[Repeated irradiation of brain metastases under stereotactic conditions: A review of the literature].
Kuntz L, Noel G.
Cancer Radiother. 2021 Jun;25(4):390-399. doi: 10.1016/j.canrad.2020.08.050. Epub 2021 Jan 9.
PMID:33431294
Metabolic and histopathological changes in the brain and plasma of rats exposed to fractionated whole-brain irradiation.
Bálentová S, Hnilicová P, Kalenská D, Baranovičová E, Muríň P, Bittšanský M, Hajtmanová E, Lehotský J, Adamkov M.
Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
Chen M, Li R, Kong Y, Shi L, Wang J, Wang Y, Xu Y, Ji Y, Hu X.